Topics:

Researchers have shown for the first time that an oncolytic immunotherapy can have therapeutic benefit in patients with advanced melanoma.

A phase III trial found that primary chemotherapy resulted in similar survival compared with primary surgery in newly diagnosed advanced ovarian cancer patients.

In this podcast ahead of the 2015 ASCO Annual Meeting, we discuss CT screening for individuals with a high risk for lung cancer with Claudia I. Henschke, MD, PhD.

Summer is officially upon us and with it comes increased personal liability and safety issues doctors and their families need to consider carefully.

Should calcium supplementation be SOP? Are all high-fat foods bad? Does the “3500 calorie rule” work? Noodle these and other nutrition questions.

Like other pharmaceuticals, ACE inhibitors have their own adverse effect profile. Find quick answers here to clinicians’ FAQs.

Pages

Subscribe to Cancer Network RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.